advertisement

Tuberculosis

09 November 2010

First clinical trial of a novel TB drug regimen in South Africa

The Global Alliance for TB Drug Development (TB Alliance) announced the launch of the first clinical trial to test a novel TB regimen designed to speed new treatments to patients.

The Global Alliance for TB Drug Development (TB Alliance) announced the launch of the first clinical trial to test a novel tuberculosis regimen in a new development paradigm designed to speed new treatments to patients.

This novel three-drug combination shows promise to treat both drug-sensitive TB (DS-TB) and multidrug-resistant TB (MDR-TB), and alter the course of the TB pandemic by shortening and simplifying treatment worldwide.

 

 

Read Health24’s Comments Policy

Comment on this story
0 comments
Comments have been closed for this article.